Exploring how cells respond to mechanical signals through Notch receptors
Integrative Approaches for Probing Cell Mechanotransduction in Health and Disease
This study is looking at how special proteins called Notch receptors help cells respond to physical signals in the body, which could lead to new ways to understand and treat different health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11012086 on NIH RePORTER |
What this research studies
This research investigates the role of Notch receptors, which are proteins that respond to mechanical signals in the body, in regulating important cellular processes such as differentiation and adhesion. The project aims to combine advanced imaging techniques and molecular tools to understand how these receptors function at a mechanical level. By studying the interactions between Notch receptors and the forces acting on cells, the research seeks to uncover new insights into how cells communicate and respond to their environment, which could have implications for various health conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions related to cell signaling or adhesion, such as certain cancers or developmental disorders.
Not a fit: Patients with conditions unrelated to cell mechanotransduction or those who do not have issues with cell signaling may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases where cell signaling and adhesion are disrupted.
How similar studies have performed: Other research has shown promising results in understanding mechanotransduction, but this specific approach to studying Notch receptors is relatively novel.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Ngo, John Tuan — Boston University (Charles River Campus)
- Study coordinator: Ngo, John Tuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.